Literature DB >> 2055350

Physiological alterations during pregnancy: impact on toxicokinetics.

D R Mattison1, E Blann, A Malek.   

Abstract

The physiological changes that occur in the alimentary, cardiovascular, pulmonary, and renal organ systems during pregnancy are designed to increase availability of nutrients to and remove wastes from the fetus. Although this is a general requirement, not all animals use the same strategies to meet these goals. These physiological adaptations will impact on toxicokinetics and may alter toxicodynamics. Absorption, distribution, metabolism, transfer between maternal and fetal compartments, and elimination will change for many xenobiotics during pregnancy. The changes in body weight, total body water, plasma proteins, body fat, and cardiac output will alter the distribution of many xenobiotics (Hytten and Leitch, 1971; Hytten and Chamberlain, 1980; Mattison, 1986). As the toxicokinetic parameters change across species, it is important to understand their impact on chemicals associated with maternal, placental, and fetal toxicity for appropriate cross-species extrapolation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055350     DOI: 10.1016/0272-0590(91)90103-b

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  8 in total

1.  Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.

Authors:  Sarah White; Elizabeth Laurenzana; Howard Hendrickson; W Brooks Gentry; S Michael Owens
Journal:  Drug Metab Dispos       Date:  2011-06-01       Impact factor: 3.922

2.  Urinary metal concentrations among mothers and children in a Mexico City birth cohort study.

Authors:  Ryan C Lewis; John D Meeker; Niladri Basu; Alison M Gauthier; Alejandra Cantoral; Adriana Mercado-García; Karen E Peterson; Martha Maria Téllez-Rojo; Deborah J Watkins
Journal:  Int J Hyg Environ Health       Date:  2018-04-22       Impact factor: 5.840

3.  Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy.

Authors:  Sarah J White; Howard P Hendrickson; William T Atchley; Elizabeth M Laurenzana; W Brooks Gentry; D Keith Williams; S Michael Owens
Journal:  Drug Metab Dispos       Date:  2014-05-19       Impact factor: 3.922

4.  Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion.

Authors:  Sarah J White; Elizabeth M Laurenzana; William Brooks Gentry; Howard P Hendrickson; David Keith Williams; Keith W Ward; Samuel Michael Owens
Journal:  Toxicol Sci       Date:  2009-06-10       Impact factor: 4.849

Review 5.  Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.

Authors:  D Krewski; J R Withey; L F Ku; M E Andersen
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

6.  Mineral Metabolism in Singleton and Twin-pregnant Dairy Goats.

Authors:  C J Härter; D S Castagnino; A R Rivera; L D Lima; H G O Silva; A N Mendonça; G F Bonfim; A Liesegang; N St-Pierre; I A M A Teixeira
Journal:  Asian-Australas J Anim Sci       Date:  2015-01       Impact factor: 2.509

Review 7.  Sex differences in pharmacokinetics and pharmacodynamics.

Authors:  Offie P Soldin; Donald R Mattison
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

8.  Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.

Authors:  Chit Shing Jackson Woo; Hani El-Nezami
Journal:  Toxins (Basel)       Date:  2016-03-23       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.